Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines

Jungseog Kang, Chien Hsiang Hsu, Qi Wu, Shanshan Liu, Adam D. Coster, Bruce A. Posner, Steven J. Altschuler, Lani F. Wu

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them - the ORACL - best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy by means of orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.

Original languageEnglish (US)
Pages (from-to)70-77
Number of pages8
JournalNature Biotechnology
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Drug Discovery
Libraries
Cells
Cell Line
Pharmaceutical Preparations
Biomarkers
Assays
Imaging techniques

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Biotechnology
  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines. / Kang, Jungseog; Hsu, Chien Hsiang; Wu, Qi; Liu, Shanshan; Coster, Adam D.; Posner, Bruce A.; Altschuler, Steven J.; Wu, Lani F.

In: Nature Biotechnology, Vol. 34, No. 1, 01.01.2016, p. 70-77.

Research output: Contribution to journalArticle

Kang, Jungseog ; Hsu, Chien Hsiang ; Wu, Qi ; Liu, Shanshan ; Coster, Adam D. ; Posner, Bruce A. ; Altschuler, Steven J. ; Wu, Lani F. / Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines. In: Nature Biotechnology. 2016 ; Vol. 34, No. 1. pp. 70-77.
@article{0bb46e6f1e414b2da286e3b117d59f0b,
title = "Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines",
abstract = "High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them - the ORACL - best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy by means of orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.",
author = "Jungseog Kang and Hsu, {Chien Hsiang} and Qi Wu and Shanshan Liu and Coster, {Adam D.} and Posner, {Bruce A.} and Altschuler, {Steven J.} and Wu, {Lani F.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1038/nbt.3419",
language = "English (US)",
volume = "34",
pages = "70--77",
journal = "Biotechnology",
issn = "0733-222X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines

AU - Kang, Jungseog

AU - Hsu, Chien Hsiang

AU - Wu, Qi

AU - Liu, Shanshan

AU - Coster, Adam D.

AU - Posner, Bruce A.

AU - Altschuler, Steven J.

AU - Wu, Lani F.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them - the ORACL - best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy by means of orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.

AB - High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them - the ORACL - best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy by means of orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.

UR - http://www.scopus.com/inward/record.url?scp=84953790713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953790713&partnerID=8YFLogxK

U2 - 10.1038/nbt.3419

DO - 10.1038/nbt.3419

M3 - Article

VL - 34

SP - 70

EP - 77

JO - Biotechnology

JF - Biotechnology

SN - 0733-222X

IS - 1

ER -